Low-grade glioma showed a similar decreased survival trend with higher CD47 mRNA that approached significance at a mean cutoff (Table 1, Figure 2c) and became significant with cutoff optimization (Figure S1d) or when median expression was used as a cutoff (Figure S2c). Here, CD47 is linked to central nervous system cancer.